Stay updated on Pembrolizumab and Binimetinib in TNBC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Binimetinib in TNBC Clinical Trial page.

Latest updates to the Pembrolizumab and Binimetinib in TNBC Clinical Trial page
- Check6 days agoChange DetectedRevision: v3.5.4 was added and the previous revision v3.5.3 was removed, indicating an update to the page's versioning metadata. This reflects a newer version of the study record on ClinicalTrials.gov.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a site-side version change without changing the displayed study details.SummaryDifference0.1%

- Check34 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.1%

- Check63 days agoChange DetectedSite CMS revision updated to v3.5.0 and previous revision v3.4.3 removed.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3; this appears to be a versioning update rather than a substantive change to study details. No study data, eligibility criteria, or outcomes were altered.SummaryDifference0.1%

- Check98 days agoChange DetectedRevision: v3.4.2 was added. The site’s previous funding-status notice and an older revision entry (v3.4.1) were removed.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab and Binimetinib in TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Binimetinib in TNBC Clinical Trial page.